Michiel Openneer

Key Account Manager Netherlands at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Michiel Openneer's Colleagues at Alnylam Pharmaceuticals
Raquel Quental

Manager Distribution & Commercial Quality Assurance

Contact Raquel Quental

Grégory Lumsden

Senior Accountant CEMEA a.i.

Contact Grégory Lumsden

Charlotte Extergren

Country Medical Director, Nordics

Contact Charlotte Extergren

Eugene Choi

Medical Science Liaison - Rare Diseases

Contact Eugene Choi

View All Michiel Openneer's Colleagues
Michiel Openneer's Contact Details
HQ
(617) 551-8200
Location
Zwolle, Overijssel, Netherlands
Company
Alnylam Pharmaceuticals
Michiel Openneer's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Michiel Openneer
Michiel Openneer currently works for Alnylam Pharmaceuticals.
Michiel Openneer's role at Alnylam Pharmaceuticals is Key Account Manager Netherlands.
Michiel Openneer's email address is ***@alnylam.com. To view Michiel Openneer's full email address, please signup to ConnectPlex.
Michiel Openneer works in the SaaS industry.
Michiel Openneer's colleagues at Alnylam Pharmaceuticals are Raquel Quental, Elena Veklenko, Grégory Lumsden, Charlotte Extergren, Kajsa Larsson, Scott Warren, Eugene Choi and others.
Michiel Openneer's phone number is (617) 551-8200
See more information about Michiel Openneer